Onconetix, Inc. Annual Income Tax Expense (Benefit) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Onconetix, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
  • Onconetix, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$56.4K.
  • Onconetix, Inc. annual Income Tax Expense (Benefit) for 2023 was -$12.6K.
  • Onconetix, Inc. annual Income Tax Expense (Benefit) for 2022 was $3.16T.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.6K -$3.16T Jan 1, 2023 Dec 31, 2023 10-K 2024-04-11
2022 $3.16T* +$2.48T Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $676B* Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.